Truist Financial Corp grew its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 13.9% in the 4th ...

IDEXX Laboratories, Inc.’s IDXX fourth-quarter performance was driven by the consistent strong performance of the Companion Animal Group (“CAG”) segment. Solid performance in the international markets ...

Baron Funds, an investment management company, released its “Baron Asset Fund” fourth quarter 2024 investor letter. A copy of ...

As of Thursday morning, IDEXX Laboratories shares are down by 0.49%, with a current price of $455.12. This implies that Erickson's 1,544 shares have a value of $597,944.

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

George Fennell, Executive Vice President at IDEXX Laboratories Inc. (NASDAQ:IDXX), a company with a market capitalization of $37.95 billion and currently trading near $463.74, recently sold 9,986 ...

IDEXX Laboratories (NASDAQ:IDXX – Free Report) had its price objective upped by Piper Sandler from $435.00 to $510.00 in a research report report published on Monday morning,Benzinga reports. Piper ...

Anne M. Szostak, a director at IDEXX Laboratories Inc. (NASDAQ:IDXX), recently sold 3,000 shares of the company's common stock. The shares were sold at an average price of $465.945, totaling ...

is up more than +7% after Wedbush upgraded the stock to outperform from neutral with a price target of $80. Clorox Co/The (CLX), Equity Residential (EQR), Everest Group Ltd (EG), Healthpeak Properties ...

Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion ...